1 권순억, "스타틴 계열 약물의 뇌졸중 예방효과"
2 허균, "뇌졸중의 분류와 치료" 3 (3): 1999
3 황남성, "뇌졸중 중풍은 왜 무서운가" 46 (46): 2006
4 강창원, "개인 유전체의 단일염기다형성 분석을 통한 발병 위험성의 예측" Busan science academy
5 Kruglyak L, "Variation is the spice of life" 27 : 234-236, 2001
6 Reed DM, "The paradox of high risk of stroke in populations with low risk of coronary heart disease" 131 : 579-588, 1990
7 Risch N, "The future of genetic studies of complex human diseases" 273 : 1516-1517, 1996
8 Adams RA, "The fibrin-derived gamma 377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease" 204 : 571-582, 2007
9 Paradowski B, "TOAST classification of Subtypes of Ischaemic Stroke : Diagnostic and Therapeutic Procedures in Stroke" 20 : 319-324, 2005
10 Wolf PA, "Secular trends in stroke incidence and mortality : the Framingham Study" 23 : 1551-1555, 1992
1 권순억, "스타틴 계열 약물의 뇌졸중 예방효과"
2 허균, "뇌졸중의 분류와 치료" 3 (3): 1999
3 황남성, "뇌졸중 중풍은 왜 무서운가" 46 (46): 2006
4 강창원, "개인 유전체의 단일염기다형성 분석을 통한 발병 위험성의 예측" Busan science academy
5 Kruglyak L, "Variation is the spice of life" 27 : 234-236, 2001
6 Reed DM, "The paradox of high risk of stroke in populations with low risk of coronary heart disease" 131 : 579-588, 1990
7 Risch N, "The future of genetic studies of complex human diseases" 273 : 1516-1517, 1996
8 Adams RA, "The fibrin-derived gamma 377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease" 204 : 571-582, 2007
9 Paradowski B, "TOAST classification of Subtypes of Ischaemic Stroke : Diagnostic and Therapeutic Procedures in Stroke" 20 : 319-324, 2005
10 Wolf PA, "Secular trends in stroke incidence and mortality : the Framingham Study" 23 : 1551-1555, 1992
11 Bogousslavsky J, "Risk Factors and Stroke Prevention. European Stroke Initiative(EUSI)" 10 (10): 12-21, 2000
12 Lewington S, "Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality : a metaanalysis of individual data for one million adults in 61 prospective studies" 360 : 1903-1913, 2002
13 Wright AF, "Population choice in mapping genes for complex diseases" 23 : 397-404, 1999
14 Miller RD, "High-density single-nucleotide polymorphism maps of the human genome" 86 : 117-126, 2005
15 Barrett JC, "Haploview : analysis and visualization of LD and haplotype maps" 21 : 263-265, 2005
16 Standeven KF, "Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism : effects on fibrin structure and function" 107 : 2326-2330, 2003
17 Howard G, "Ethnic differences in stroke mortality between non- Hispanic whites, Hispanic whites, and blacks. The National Longitudinal Mortality Study" 25 : 2120-2125, 1994
18 Whisnant JP, "Effectiveness versus efficacy of treatment of hypertension for stroke prevention" 46 : 301-307, 1996
19 Carter AM, "Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation" 99 : 2423-2426, 1999
20 Welin L, "Analysis of risk factors for stroke in a cohort of men born in 1913" 317 : 521-526, 1987
21 Sachidanandam R, "A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms" 409 : 928-933, 2001